This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

While LDL cholesterol remains a crucial target in cardiovascular prevention, it is important to look beyond this traditional marker.

Some studies suggest that up to 80% of women with PCOS in the U.S. have overweight or obesity.

A new study provides some insights, revealing what may be behind my physical decline.